Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05739734
EARLY_PHASE1

Safety of CRIS100 on Treatment Spinal Cord Injury

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours of the trauma.

Official title: Clinical Safety Study of the Application of CRIS100 in Participants With Acute Spinal Cord Injury

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

5

Start Date

2026-04

Completion Date

2027-05

Last Updated

2026-02-03

Healthy Volunteers

No

Interventions

DRUG

CRIS100

local application of CRIS100